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Abstract
Background: Determination of the relaxation time constants T1 and T2 with quantitative magnetic resonance
imaging is increasingly used for both research and clinical practice. Recently, groups have been formed within
the Society of Cardiovascular Magnetic Resonance to address issues with relaxometry. However, so far they have
avoided specific recommendations on methodology due to lack of consensus and current evolving research.
Standardised widely available software may simplify this process.
The purpose of the current study was to develop and validate vendor-independent T1 and T2 mapping modules
and implement those in the versatile and widespread software Segment, freely available for research and FDA
approved for clinical applications.
Results: The T1 and T2 mapping modules were developed and validated in phantoms at 1.5 T and 3 T with reference
standard values calculated from reference pulse sequences using the Nelder-Mead Simplex optimisation method. The
proposed modules support current commonly available MRI pulse sequences and both 2- and 3-parameter curve
fitting. Images acquired in patients using three major vendors showed vendor-independence. Bias and variability
showed high agreement with T1 and T2 reference standards for T1 (range 214–1752 ms) and T2 (range 45–338 ms),
respectively.
Conclusions: The developed and validated T1 and T2 mapping and quantification modules generated relaxation maps
from current commonly used MRI sequences and multiple signal models. Patient applications showed usability for
three major vendors.
Keywords: T1, T2, Mapping, Quantitative magnetic resonance imaging
Background
Quantitative magnetic resonance imaging (MRI) is increas-
ingly used for several different applications in both research
and clinical practice. For cardiac MRI, T1 quantification
enables measurement of myocardial extracellular volume
[1–3], whereas T2 mapping detects oedema in acute myo-
cardial infarction [4]. The Society of Cardiovascular Mag-
netic Resonance (SCMR) has also recently formed groups
and provides general recommendations on use of mapping
for research and clinical applications [5, 6]. However, spe-
cific recommendations have been avoided so far due to lack
of consensus and current evolving research [6]. The Society
is thus awaiting this field to develop so that guidelines can
be properly formulated. Standardised software may simplify
and speed up this process.
Further, cancer imaging has benefited from T1 to T2
mapping for determining early tumour progression in
brain [7], and provides improved discrimination between
benign and malign findings in suspected prostate cancer
[8]. Also, oxygen saturation in blood has been accurately
measured noninvasively by T2 mapping in children with
complex congenital heart disease, yielding an opportunity
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to potentially avoid cardiac catheterisation for follow-up
studies in children [9].
Different numerical algorithms can be used to com-
pute T1 and T2 relaxation maps and therefore inline
map generation may vary between MRI vendors. Also,
most inline systems do not present the curve fit, which,
if visualised, can be used as a marker of accuracy. More-
over, the algorithms used are not openly documented. A
previous open-source software overcame these limita-
tions, but is only to be used for research [10]. Last but
not least, current available software is generally limited
in signal models and fitting options.
The purpose of this study was to develop, validate and
openly document T1 and T2 relaxation map modules
with multiple signal models, test those in images ac-
quired using three major vendors, and implement the
validated modules in freely available software for
research [11].
Implementation
The T1 and T2 mapping modules were developed and
validated in phantoms with reference standard T1 and
T2 values calculated from reference spin echo (SE) pulse
sequences using the Nelder-Mead Simplex optimisation
method available in Matlab (Math Works, Natick, MA;
2014a). The proposed modules support current com-
monly available MRI pulse sequences and both 2- and 3-
parameter curve fitting (Table 1).
Table 1 Supported sequences and signal fitting models
Supported signal models
Supported sequences 3-parameter fit model 2-parameter fit model
T1 spin-echo IR (magnitude images) S(t) = |A (1 − B exp(−t/T1))| S(t) = |A (1 − 2 exp(−t/T1))|
T1 PSIR S(t) = A (1 − B exp(−t/T1)) S(t) = A (1 − 2 exp(−t/T1))
T1 saturation recovery balanced SSFP S(t) = A (1 − B exp(−t/T1)) S(t) = A (1 − exp(−t/T1))
T1 MOLLI/T1 Look-Locker correction (magnitude images) S(t) = |A (1 − B exp(−t/T1*))|; T1 = T1* (B − 1) n/a
T1 MOLLI/T1 Look-Locker correction (PSIR images) S(t) = A (1 − B exp(−t/T1*)); T1 = T1* (B − 1) n/a
T2 spin echo (multi-echo and single-echo) S(t) = A exp(−t/T2) + B; B > 0 S(t) = A exp(−t/T2)
T2-prepared balanced SSFP S(t) = A exp(−t/T2) + B; B > 0 S(t) = A exp(−t/T2)
IR inversion recovery, PSIR phase sensitive inversion recovery, MOLLI modified Look-Locker inversion recovery, SSFP steady-state free precession
Fig. 1 The image shows the graphical user interface of the T1 mapping module (the T2 mapping module shares the design). An example of a
cardiac pre-contrast MOLLI T1 map at 1.5 T in a healthy volunteer is shown. Both pixel-wise mapping, for the whole image and ROI-based, and
ROI-based global mean mapping are available. The residuals of the curve fit for both T1 and T2 mapping can be visualised, indicating areas within
the image that have a higher deviation from the curve and thus less accurate T1 and T2 values
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The T1 mapping module graphical user interface is
shown in Fig. 1 (the T2 mapping module shares the
design). Both ROI-based global mean mapping and pixel-
wise mapping for the whole image and ROI-based are
available. Further, the residuals of the curve fit for both T1
and T2 mapping can be visualised, indicating areas within
the image that have a higher deviation from the curve and
thus less accurate T1 and T2 values.
The validated modules were finally implemented in
the software Segment, freely available for research
(http://www.medviso.com) [11].
Since Segment already includes a validated module for
T2* mapping and quantification [12], this topic was not
covered in the current study.
Phantom setup and imaging
A Eurospin (Diagnostic Sonar, Livingston, UK) phantom
encompassing 12 gadolinium/agarose gel phantoms was
used for validation of the proposed modules. The phan-
toms were scanned at both 1.5 T and 3 T (Siemens Aera
and Prisma, Erlangen, Germany). Single-echo spin-echo
sequences were used for acquiring the reference T1 and
T2 values. Pulse sequence parameters are presented in
Table 2. The magnetization was allowed to fully recover
between spin radiofrequency excitations.
Commonly available T1 and T2 mapping sequences
were used to acquire images of the phantom, and the
proposed modules were applied to generate T1 and T2
relaxation constant maps. The sequences were based on
a free-breathing single-shot balanced steady-state free
precession (bSSFP) sequence.
T1 mapping
Pixelwise T1 estimates were initialized using a
lookup-table search performed in two steps in a T1
interval of 0–4000 ms. First, a step of 50 ms between
lookup-table entries was applied for high perform-
ance. Thereafter, to find the optimal value, a second
search was performed using a 5 ms difference be-
tween lookup-table entries within 100 ms of the entry
found in the first step. In these two steps, depending
on the pulse sequence, ideal inversion/saturation effi-
ciency was assumed and each pixel was normalized
with the maximum absolute value within its time-
series. The T1 lookup-table entry resulting in the
minimum sum of absolute error was chosen as the
initial T1 value.
Table 2 Typical MRI sequence parameters
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off 64 06:45:20
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n/a off 64 05:20:00
T2 spin echo
(multi-echo)
[9, 18, 27, 36, 45,
54, 63, 72, 81, 90,
99, 108, 117, 126,
135, 144]




n/a off 62.5 00:06:24
T2-prepared balanced
SSFP




T2p range = 25 − 200; ΔT2p = 5; 2 208.32 00:12:20
IR inversion recovery, PSIR phase sensitive inversion recovery, MOLLI modified Look-Locker inversion recovery, SSFP steady-state free precession
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Following T1 initialization, pixel T1 values were refined
using a C implementation of the Nelder-Mead Simplex
nonlinear optimisation algorithm [13]. Convergence was
assumed when the maximum T1 absolute difference be-
tween two simplexes was less than 0.10 ms. The C imple-
mentation was performed to reduce computation times
and was thus not used for calculating the ROI-based glo-
bal mean where instead the pre-implemented Matlab
fminsearch method [14] was sufficient.
For T1 reference values, an inversion recovery (IR)
single-echo spin echo sequence was used with a short
echo time and long repetition time (Table 2). Two varia-
tions of the free-breathing bSSFP sequence were used
for T1 mapping; one based on SR and one based on IR
preparation pulses respectively applied before imaging
readout. At 1.5 T, T1 was also estimated using a breath-
hold MOLLI sequence with pre- and post-contrast car-
diac configurations (5(3b)3 and 4(1b)3(1b)2) for analysis
of phantoms with T1 > 600 ms and T1 < 600 ms, respect-
ively. Since the MOLLI acquisition alters the recovery
curve in itself, inducing T1* measurements, the Look-
Locker correction from T1* to T1 was performed
(Table 1), as previously proposed [15]. Magnitude images
were used to estimate T1 from spin echo, SR-bSSFP and
MOLLI sequences. For IR-bSSFP, the phase and magni-
tude images were extracted in order to reconstruct
phase-sensitive inversion recovery (PSIR) images, as pre-
viously proposed [16].
T2 mapping
The initial T2 estimate was initialized by a weighted 2-
parameter linear regression of the signal logarithm [17].
The estimation was repeated for stepwise truncation of
the maximum echo time until three data points
remained. The T2 estimate resulting in the minimum
sum of absolute error over all data points was chosen as
the initial T2 estimate.
Following the T2 initialisation, all pixels with T2 values
outside the interval 0 < T2 < 400 ms were excluded from
further analysis and the final T2 estimate was refined
using the above-mentioned nonlinear optimisation algo-
rithm. Convergence was assumed when the maximum
T2 absolute difference between two simplexes was less
than 0.10 ms. Pixels that were not refined with nonlinear
optimization were set to 0 in the resulting T2 map.
For T2 reference values, a single-echo spin echo
sequence was used. The free-breathing bSSFP se-
quence used T2 preparation pulses for T2 mapping.
An SR-prepared image with a short saturation time
was used for the T2 calculation in order to improve
the 3-parameter curve fit [18]. Magnitude images
were used to estimate T2 from both spin echo and
bSSFP sequences.
Residual calculation for T1 and T2 mapping
Curve-fit residuals for T1 and T2 mapping were calcu-
lated as the average absolute difference between the fit-
ted curve and corresponding pixel values. Residuals were
normalised relative to the maximum absolute pixel value
within its time-series and reported as a percentage.
Application on human MR images
The developed and validated T1 and T2 mapping mod-
ules were applied on images acquired from three major
vendors. Standard available sequences were used on Sie-
mens (1.5 T Aera and 3 T Prisma, Erlangen, Germany)
with 60-channel phased array coils and a 20-channel
head coil; Philips (1.5 T Achieva, Best, the Netherlands)
with 32-channel phased array coils; and on GE (3 T Dis-
covery 750w, General Electrics, USA) with a GEM flex
medium array coil. The local ethics committee approved
the research protocol and all subjects provided written
consent.
Table 3 Computational times for pixel-wise mapping in the complete image and in a selected ROI, respectively
Pixel-wise (complete image) Pixel-wise (ROI only)
T1 spin-echo IR (magnitude images) 2.5 s (3 parameters, 17 images, 128 × 128 images, 13
435 refined pixels)
0.03 s (3 parameters, 17 images, 200 pixels,
152 refined pixels)
T1 PSIR 11.7 s (3 parameters, 17 images, 192 × 144 matrix,
26 597 refined pixels)
0.15 s (3 parameters, 17 images, 200 pixels,
200 refined pixels)
T1 saturation recovery balanced SSFP 11.2 s (3 parameters, 15 images, 192 × 144 matrix,
26 594 refined pixels)
0.09 s (3 parameters, 15 images, 202 pixels,
202 refined pixels)
T1 MOLLI/T1 Look-Locker correction (magnitude
and PSIR images)
6.4 s (3 parameters, 9 images, 192 × 144 matrix, 25
128 refined pixels)
0.05 s (3 parameters, 9 images, 202 pixels,
198 refined pixels)
T2 spin echo (single-echo and multi-echo) 1.12 s (2 parameters, 15 images, 128 × 128 matrix, 9
175 refined pixels)
0.04 s (2 parameters, 15 images, 207 pixels,
160 refined pixels)
T2-prepared balanced SSFP 11.7 s (3 parameters, 37 images, 192 × 144 matrix,
16 322 refined pixels)
0.14 s (3 parameters, 37 images, 207 pixels,
184 refined pixels)
The ROI-based global mean fitting takes less than 2 s for all sequences and is not listed. Performance was tested at a 2.4 GHz, 8 GB RAM, SSD HDD standard lap-
top running the MS Windows 7 64-bit operating system
IR inversion recovery, PSIR phase sensitive inversion recovery, MOLLI modified Look-Locker inversion recovery, SSFP steady-state free precession
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Statistics
Bias and variability were determined using the modified
Bland-Altman analysis. The bias and variability percent-
ages were computed as the difference between the pro-
posed method and the reference standard divided with
the reference standard values. Values were expressed as
mean ± SD and 95 % limits of agreement.
Results
Computational times were generally fast independent of
amount of information, i.e. for both full image and ROI-
based calculations (Table 3).
The T1 and T2 reference values ranged from 214 to
1643 ms and 46–338 ms for 1.5 T, and 229–1752 ms
and 45–316 ms for 3 T, respectively. Phantom validation
results are shown for 1.5 T and 3 T (Fig. 2) and corre-
sponding curve fit examples at 1.5 T (Fig. 3). The T1
bias and variability at 1.5 T were 0.8 ± 8 ms (0.2 ± 1.2 %)
for SR-bSSFP using the 3-parameter fit, and 24 ± 9 ms
(3.5 ± 2.3 %) using the 2-parameter fit. Corresponding
bias and variability for PSIR-bSSFP at 1.5 T were 3.2 ±
3.8 ms (0.6 ± 1.0 %) and −31 ± 26 ms (−3.5 ± 2.1 %). For
cardiac MOLLI at 1.5 T the bias and variability was −39 ±
45 ms (−3.3 ± 3.4 %). The higher variability for MOLLI
was related to low T2, with errors above 5 % originating
from phantoms with reference T2 values < 60 ms.
The T1 bias and variability at 3 T were for SR-bSSFP −
6 ± 11 ms (−0.7 ± 0.9 %) when applying a 3-parameter fit,
whereas a 2-parameter fit yielded 22 ± 13 ms (2.8 ±
1.6 %). Corresponding bias and variability for PSIR-
Fig. 2 Modified Bland-Altman analyses of the phantom validation data at 1.5 T (left column) and 3 T (right column). All curve fits were performed
using the 3-parameter fit. The dotted and dashed lines represent bias and 95 % limits of agreement. A generally high agreement was found. The
T1 outliers dependent on low T2 (<60 ms) found using the MOLLI sequence at 1.5 T are encircled in red. bSSFP = balanced steady-state free pre-
cession; MOLLI = modified Look-Locker inversion recovery; SR = saturation recovery; IR = inversion recovery
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bSSFP at 3 T were −9 ± 13 ms (−1.1 ± 1.0 %) and −36 ±
33 ms (−3.3 ± 2.1 %).
The T2 bias and variability were 2.8 ± 2.7 ms (1.9 ±
2.0 %) at 1.5 T and −0.7 ± 3.6 ms (0.2 ± 2.7 %) at 3 T
using the 3-parameter fit.
Figure 4 shows T1 and T2 maps from human applica-
tions for three major vendors.
Discussion
The developed and validated T1 and T2 mapping mod-
ules generated maps from commonly used MRI se-
quences and multiple signal models. Generally low bias
and variability were found compared with reference
standard measurements in phantoms. Patient applica-
tions showed usability for three major vendors. The
main software is freely available for research and well
documented.
The proposed algorithms showed particularly good
agreement with the reference standard for saturation re-
covery sequences. However, T1 was underestimated by
MOLLI when also phantoms with low T2 values
(<60 ms) were included. This is similar to previously
published data showing T2 sensitivity for MOLLI T1
mapping, with approximately 5 % error in T1 values for
T2 below 30 ms [19]. This underestimation may be cor-
rected for by using recently proposed lookup-table
methods [20]. Another explanation for the increased
variability using MOLLI compared to saturation recov-
ery may be the reduced number of sampling points used
for MOLLI in this study.
The slightly higher, albeit not large, variability shown
for the T2 prepared sequence may be explained by lim-
ited signal-to-noise ratio. The T2 prepared mapping may
be improved by acquiring several data points (echoes),
especially late TE images since an offset is known to
occur. Another solution is to acquire fewer echoes and
instead add a saturation recovery acquisition, as per-
formed in the current study [18]. This solution only adds
a single heartbeat to the acquisition time (approximately
1 s) and is therefore applicable in most patients. Prefera-
bly, more than 1 saturation recovery acquisition should
be added for averaging. This number may on the other
hand need to be optimised in the individual case, espe-
cially in cardiac disease where the patient may have diffi-
culties extending the duration of the breath hold.
The proposed software modules include both 2- and
3-parameter T1 and T2 fitting. In theory, a reduced
number of parameters should result in reduced random
errors (i.e. reduced variability) while however also lead-
ing to a risk of introducing a bias due to increased sensi-
tivity to measurement imperfections. In cardiac MRI, 3-
parameter T1 curve fitting is commonly applied to re-
duce bias associated with imperfect preparation-pulse ef-
ficiency and/or effects from applied readout pulses [21,
22]. The 3-parameter curve fit has also been suggested
for cardiac T2 mapping when using the T2-prepared
bSSFP sequence [18]. Unbiased 2-parameter fitting for
cardiac T1 mapping has recently been proposed [23],
which may lead to an increased need for software
Fig. 3 Example curve fits for T1 and T2 at 1.5 T in two phantoms.
The solid lines represent estimated relaxation curves. bSSFP =
balanced steady-state free precession; MOLLI = modified Look-Locker
inversion recovery; SR = saturation recovery
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supporting 2-parameter T1 mapping in the near future.
Clinical validation was not performed as part of the
current study, as it is important to first validate algo-
rithms that are to be applied in future in vivo studies. Fi-
nally, albeit data from three major vendors were tested,
other vendors may use other sequences or reporting of
data for fitting, and future studies may benefit from in-
cluding additional vendors.
Limitations
In the current modules neither rigid nor non-rigid regis-
tration has been implemented. These methods may in
some cases improve the diagnostic quality and are sub-
ject to future improvements and investigations and will
be included in future updates of the modules. Further,
some MRI vendors use private dicom headers for data
needed for T1 and T2 mapping. These headers may
change between MRI vendor software updates. Current
known private dicom headers have been implemented in
the proposed modules and future updates aim to cover
these changes.
Conclusions
The developed and validated T1 and T2 mapping mod-
ules generated relaxation maps from current commonly
used MRI sequences and multiple signal models. Patient
applications showed usability for three major vendors.
The main software is freely available for research and
well documented.
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